Skip Navigation

A Phase I/II, Open-Label, Multicenter Study to Investigate the Safety and Preliminary Efficacy of Nktr-214 in Combination with Pembrolizumab in Patients with Locally Advanced or Metastatic Solid Tumors

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT03138889

Study #:
STUDY00145029

Start Date:
May 28, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03138889

View Complete Trial Details & Eligibility at ClinicalTrials.gov